SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: RT who wrote (5738)3/2/1998 9:13:00 AM
From: Tunica Albuginea  Read Replies (1) | Respond to of 23519
 
Well put MissLil; you just have to be burned by a drug a few times to appreciate their crippling effects; for those that wonder, Vtach in your post means ventricular tachycardia ( a deadly arrhythmia ). Something that was missed when Hismanal and other popular once a day antihistamine were tested and approved. Now they are off the market.

TA



To: RT who wrote (5738)3/2/1998 11:59:00 AM
From: Brian Malloy  Read Replies (1) | Respond to of 23519
 
"He had been using the needle, but he said it lacked spontaneity."

I suppose he calls taking a pill and waiting an hour for it take effect spontaneous?



To: RT who wrote (5738)3/2/1998 8:35:00 PM
From: Edderd  Respond to of 23519
 
RT It's expected. The hype will be incredible. there is so much sexual inadequacy out there and it's all being classified as ED when it really isn't. Viagra will be a short term cure for those. They didn't mention (maybe you didn't) how the prostate cancer patient was treated. RRP , external beam, seeds, hormones, watchful waiting or proton accelerator. A fair number of prostate cancer patients are not impotent, and perfect candidates for Viagra. Big fellow was right the revenues will be incredible and some of it sustainable. Vivus needs the international market to boost it's sales in the short and long term. I beleive this is very doable. Not much sense worrying about Viagra unless your are long in PFE. IMO Ed